All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-YC0587 | Mouse anti-Kdm5d T cell receptor (1), pCDTCR1 | Mouse | 1 | Mouse | KCSRNRQYL | H2-Dᵇ | Lentiviral vector | |
TCR-YC0588 | Mouse anti-Kdm5d T cell receptor (2), pCDTCR1 | Mouse | 2 | Mouse | KCSRNRQYL | H2-Dᵇ | Lentiviral vector | |
TCR-YC0589 | Mouse anti-Kdm5d T cell receptor (3), pCDTCR1 | Mouse | 3 | Mouse | KCSRNRQYL | H2-Dᵇ | Lentiviral vector | |
TCR-YC0590 | Mouse anti-Kdm5d T cell receptor (7), pCDTCR1 | Mouse | 7 | Mouse | KCSRNRQYL | H2-Dᵇ | Lentiviral vector | |
TCR-YC0591 | Mouse anti-Kdm5d T cell receptor (9), pCDTCR1 | Mouse | 9 | Mouse | KCSRNRQYL | H2-Dᵇ | Lentiviral vector | |
TCR-YC0592 | Mouse anti-Kdm5d T cell receptor (10), pCDTCR1 | Mouse | 10 | Mouse | KCSRNRQYL | H2-Dᵇ | Lentiviral vector | |
TCR-YC0593 | Mouse anti-Kdm5d T cell receptor (17), pCDTCR1 | Mouse | 17 | Mouse | KCSRNRQYL | H2-Dᵇ | Lentiviral vector | |
TCR-YC0594 | Mouse anti-Kdm5d T cell receptor (20), pCDTCR1 | Mouse | 20 | Mouse | KCSRNRQYL | H2-Dᵇ | Lentiviral vector | |
TCR-YC0595 | Mouse anti-Kdm5d T cell receptor (22), pCDTCR1 | Mouse | 22 | Mouse | KCSRNRQYL | H2-Dᵇ | Lentiviral vector | |
TCR-YC0596 | Mouse anti-Kdm5d T cell receptor (27), pCDTCR1 | Mouse | 27 | Mouse | KCSRNRQYL | H2-Dᵇ | Lentiviral vector | |
TCR-YC0597 | Mouse anti-Kdm5d T cell receptor (B6.2.16), pCDTCR1 | Mouse | B6.2.16 | Mouse | KCSRNRQYL | H2-Dᵇ | Lentiviral vector | |
TCR-YC0598 | Mouse anti-Kdm5d T cell receptor (P14), pCDTCR1 | Mouse | P14 | Mouse | KCSRNRQYL | H2-Dᵇ | Lentiviral vector | |
TCR-YC0599 | Human anti-KDM5D T cell receptor (YC32), pCDTCR1 | Human | YC32 | Human | FIDSYICQV | HLA-A*02:01 | Lentiviral vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION